• Issue

    Arthritis & Rheumatism: Volume 43, Issue 11

    2381-2618
    November 2000
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Editorials

Tumor necrosis factor α blockers and the induction of anti-DNA autoantibodies

David S. Pisetsky, 
  • Pages: 2381-2382
  • First Published: 26 March 2001

Clinical Science

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials

P. J. Charles,  R. J. T. Smeenk,  J. De Jong,  M. Feldmann,  R. N. Maini, 
  • Pages: 2383-2390
  • First Published: 26 March 2001

Systemic anti–tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor α synthesis

Ann-Kristin Ulfgren,  Ulf Andersson,  Marianne Engström,  Lars Klareskog,  Ravinder N. Maini,  Peter C. Taylor, 
  • Pages: 2391-2396
  • First Published: 26 March 2001

Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations

Marko H. Neva,  Markku J. Kauppi,  Hannu Kautiainen,  Reijo Luukkainen,  Pekka Hannonen,  Marjatta Leirisalo-Repo,  Martti Nissilä,  Timo Möttönen, 
  • Pages: 2397-2401
  • First Published: 26 March 2001

Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: A multicenter cohort study

Lynn R. Spiegel,  Rayfel Schneider,  Bianca A. Lang,  Nina Birdi,  Earl D. Silverman,  Ronald M. Laxer,  Derek Stephens,  Brian M. Feldman, 
  • Pages: 2402-2409
  • First Published: 26 March 2001

The genetic contribution to radiographic hip osteoarthritis in women: Results of a classic twin study

Alexander J. MacGregor,  Leto Antoniades,  Matthew Matson,  Toby Andrew,  Tim D. Spector, 
  • Pages: 2410-2416
  • First Published: 26 March 2001

Association of genotypes affecting the expression of interleukin-1β or interleukin-1 receptor antagonist with osteoarthritis

Verena Moos,  Martin Rudwaleit,  Volker Herzog,  Kai Höhlig,  Joachim Sieper,  Brigitte Müller, 
  • Pages: 2417-2422
  • First Published: 26 March 2001

The role of subchondral insufficiency fracture in rapid destruction of the hip joint: A preliminary report

Takuaki Yamamoto,  Peter G. Bullough, 
  • Pages: 2423-2427
  • First Published: 26 March 2001

Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging

G. P. Th. Bosma,  M. J. Rood,  T. W. J. Huizinga,  B. A. De Jong,  E. L. E. M. Bollen,  M. A. Van Buchem, 
  • Pages: 2428-2436
  • First Published: 26 March 2001

Severe organ involvement in systemic sclerosis with diffuse scleroderma

Virginia D. Steen,  Thomas A. Medsger Jr., 
  • Pages: 2437-2444
  • First Published: 26 March 2001

Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trial

Philip J. Clements,  Eric L. Hurwitz,  Weng Kee Wong,  James R. Seibold,  Maureen Mayes,  Barbara White,  Fredrick Wigley,  Michael Weisman,  Walter Barr,  Larry Moreland,  Thomas A. Medsger Jr.,  Virginia D. Steen,  Richard W. Martin,  David Collier,  Arthur Weinstein,  Edward Lally,  John Varga,  Steven R. Weiner,  Brian Andrews,  Micha Abeles,  Daniel E. Furst, 
  • Pages: 2445-2454
  • First Published: 26 March 2001

Increased interleukin-17 production in patients with systemic sclerosis

Kazuhiro Kurasawa,  Koichi Hirose,  Hideki Sano,  Hideharu Endo,  Hiroshi Shinkai,  Yasushi Nawata,  Katsuhiko Takabayashi,  Itsuo Iwamoto, 
  • Pages: 2455-2463
  • First Published: 26 March 2001

Autoantibodies to fibrillin 1 in systemic sclerosis: Ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles

Filemon K. Tan,  Frank C. Arnett,  John D. Reveille,  Chul Ahn,  Stephan Antohi,  Takeshi Sasaki,  Kioshi Nishioka,  Constantin A. Bona, 
  • Pages: 2464-2471
  • First Published: 26 March 2001

Vascular endothelial growth factor production in polymyalgia rheumatica

Riccardo Meliconi,  Lia Pulsatelli,  Paolo Dolzani,  Luigi Boiardi,  Pierluigi Macchioni,  Carlo Salvarani,  Tania Silvestri,  Luigi Frizziero,  Andrea Facchini, 
  • Pages: 2472-2480
  • First Published: 26 March 2001

Epidemiology of Wegener's granulomatosis in Northern Norway

Wenche Koldingsnes,  Hans Nossent, 
  • Pages: 2481-2487
  • First Published: 26 March 2001

Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine

Hyon K. Choi,  Marjan C. Slot,  Guoli Pan,  Charyl A. Weissbach,  John L. Niles,  Peter A. Merkel, 
  • Pages: 2488-2492
  • First Published: 26 March 2001

The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome

Afton L. Hassett,  John D. Cone,  Sondra J. Patella,  Leonard H. Sigal, 
  • Pages: 2493-2500
  • First Published: 26 March 2001

Basic Science

Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal–regulated kinase, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis

Georg Schett,  Makiyeh Tohidast-Akrad,  Josef S. Smolen,  Beatrice Jahn Schmid,  Carl-Walter Steiner,  Peter Bitzan,  Peter Zenz,  Kurt Redlich,  Qingbo Xu,  Günter Steiner, 
  • Pages: 2501-2512
  • First Published: 26 March 2001

Intercellular adhesion molecule 1 underlies the functional heterogeneity of synovial cells in patients with rheumatoid arthritis: Involvement of cell cycle machinery

Yoshiya Tanaka,  Masashi Nomi,  Koichi Fujii,  Stefan Hübscher,  Akihiko Maruo,  Shigeru Matsumoto,  Yuichiro Awazu,  Kazuyoshi Saito,  Sumiya Eto,  Yasuhiro Minami, 
  • Pages: 2513-2522
  • First Published: 26 March 2001

Expression of osteoclast differentiation factor in rheumatoid arthritis

Yukio Shigeyama,  Thomas Pap,  Peter Kunzler,  Beat R. Simmen,  Renate E. Gay,  Steffen Gay, 
  • Pages: 2523-2530
  • First Published: 26 March 2001

Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis

Thomas Pap,  Willemijn H. Van Der Laan,  Karlfried R. Aupperle,  Renate E. Gay,  Jan H. Verheijen,  Gary S. Firestein,  Steffen Gay,  Michel Neidhart, 
  • Pages: 2531-2536
  • First Published: 26 March 2001

Annexin I surface binding sites and their regulation on human fibroblast-like synoviocytes

Annaleise V. Sampey,  Paul Hutchinson,  Eric F. Morand, 
  • Pages: 2537-2542
  • First Published: 26 March 2001

Sex and site differences in cartilage development: A possible explanation for variations in knee osteoarthritis in later life

Graeme Jones,  Michael Glisson,  Kristen Hynes,  Flavia Cicuttini, 
  • Pages: 2543-2549
  • First Published: 26 March 2001

Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95

Roswitha Sgonc,  Matthias S. Gruschwitz,  Guenther Boeck,  Norbert Sepp,  Johann Gruber,  Georg Wick, 
  • Pages: 2550-2562
  • First Published: 26 March 2001

Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints

Zhibao Mi,  Steven C. Ghivizzani,  Eric R. Lechman,  Daniel Jaffurs,  Joseph C. Glorioso,  Christopher H. Evans,  Paul D. Robbins, 
  • Pages: 2563-2570
  • First Published: 26 March 2001

The role of CD40 ligand and tumor necrosis factor α signaling in the transgenic K/BxN mouse model of rheumatoid arthritis

Diego Kyburz,  Dennis A. Carson,  Maripat Corr, 
  • Pages: 2571-2577
  • First Published: 26 March 2001

Unmethylated oligo-DNA containing CpG motifs aggravates collagen-induced arthritis in mice

Masayuki Miyata,  Hiroko Kobayashi,  Tomomi Sasajima,  Yukio Sato,  Reiji Kasukawa, 
  • Pages: 2578-2582
  • First Published: 26 March 2001

Oral antibiotics as a novel therapy for arthritis: Evidence for a beneficial effect of intestinal Escherichia coli

Edward E. S. Nieuwenhuis,  Maarten R. Visser,  Annemieke Kavelaars,  Pieter M. Cobelens,  Andre Fleer,  Wil Harmsen,  Jan Verhoef,  Louis M. A. Akkermans,  Cobi J. Heijnen, 
  • Pages: 2583-2589
  • First Published: 26 March 2001

Therapeutic efficacy of a novel membrane-targeted complement regulator in antigen-induced arthritis in the rat

Stuart M. Linton,  Anwen S. Williams,  Ian Dodd,  Richard Smith,  Bryan D. Williams,  B. Paul Morgan, 
  • Pages: 2590-2597
  • First Published: 26 March 2001

Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride

Paul J. Christner,  Carol M. Artlett,  Raymond F. Conway,  Sergio A. Jiménez, 
  • Pages: 2598-2605
  • First Published: 26 March 2001

Case Reports

Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis

Bradley J. Bloom, 
  • Pages: 2606-2608
  • First Published: 26 March 2001

Concise Communications

Serious liver disease in a patient receiving methotrexate and leflunomide

Michael E. Weinblatt MD,  Jonathan A. Dixon MD,  Kenneth R. Falchuk MD, 
  • Pages: 2609-2611
  • First Published: 26 March 2001

Twins concordant for juvenile rheumatoid arthritis

Sampath Prahalad MD,  Mary H. Ryan MA,  Edith S. Shear MSW,  Susan D. Thompson PhD,  David N. Glass MD,  Edward H. Giannini MSc, DrPH, 
  • Pages: 2611-2612
  • First Published: 26 March 2001

Possible association of “shrinking lung” and anti-ro/ssa antibody

Masaru Ishii MD,  Hiroshi Uda MD,  Tamotsu Yamagami MD, PhD,  Yoshinori Katada MD, PhD, 
  • Pages: 2612-2613
  • First Published: 26 March 2001

Letters

Lack of Epstein-Barr virus infection of synovial membranes in patients with rheumatoid arthritis: Comment on the article by Niedobitek et al

Pierre Brousset MD, PhD, 
  • Page: 2614
  • First Published: 26 March 2001

Serum matrix metalloproteinase 3 as a predictor of joint destruction in rheumatoid arthritis: Comment on the article by Yamanaka et al

Derek L. Mattey PhD,  Peter T. Dawes FRCP,  Nap T. Cheung MD, MRCP, 
  • Pages: 2614-2615
  • First Published: 26 March 2001

Reply

Hisashi Yamanaka MD,  Naoyuki Kamatani MD, 
  • Page: 2615
  • First Published: 26 March 2001

Folic acid supplementation and methotrexate efficacy: Comment on articles by Schiff, Emery et al, and others

Vibeke Strand MD,  Sarah L. Morgan MD, RD,  Joseph E. Baggott PhD,  Graciela S. Alarcón MD, MPH, 
  • Pages: 2615-2616
  • First Published: 26 March 2001

Antiperinuclear factor and antikeratin antibody in the diagnosis of rheumatoid arthritis: Comment on the article by Kim and Weisman

M. Nergis Yanmaz Alnigenis MD,  Peter Barland MD, 
  • Page: 2617
  • First Published: 26 March 2001

IgG glycosylation status as a clinical predictor of rheumatoid arthritis: Comment on the article by Kim and Weisman

David A. Isenberg MD, FRCP,  Adam Young MD, FRCP, 
  • Pages: 2617-2618
  • First Published: 26 March 2001

Systemic sclerosis sine scleroderma: Comment on the article by Poormoghim et al

Gleb Slobodin MD,  Itzhak Rosner MD,  Michael Rozenbaum MD,  Jochanan E. Naschitz MD,  Elimelech Zuckerman MD,  Daniel Yeshurun MD,  Bruce Rappaport, 
  • Page: 2618
  • First Published: 26 March 2001

Errata

Free Access

Erratum

  • Page: 2618
  • First Published: 26 March 2001